Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include common findings: Iris coloboma. 5 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Eyes | 2 | Developmental cataract, Retinal atrophy |
Muscles |
MIR204 encodes microRNA 204. Highest expression in Adipose Subcutaneous (0.0 TPM) and Adipose Visceral Omentum (0.0 TPM).
Familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome is associated with mutations in the MIR204 gene on chromosome 9.
MIR204 is classified as a druggable target with score 0.0.
Genetic testing for MIR204 is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome has been reported in the published literature.
Phenotype severity distribution: 1 common feature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome.
189 publications have been identified in PubMed for familial progressive retinal dystrophy-iris coloboma-congenital cataract syndrome. Kisho has analyzed 83 by research type. Research spans Review / Meta-Analysis (33%), Epidemiology / Natural History (33%), and Basic Science / Preclinical (20%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 27 |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 9:49 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Retinal atrophy |
Age of onset: at birth.
Disease patterns and progression | 27 | 33% |
Laboratory research | 17 | 20% |
Testing and diagnosis research | 4 | 5% |
Patient case studies | 4 | 5% |
New treatment approaches | 2 | 2% |
Other research | 1 | 1% |
Clinical study results | 1 | 1% |
Katsev BD (2026). [PMID: 42044894](https://pubmed.ncbi.nlm.nih.gov/42044894/). *Aerosp Med Hum Perform*. [Review / Meta-Analysis]
Dick HB (2026). [PMID: 41248686](https://pubmed.ncbi.nlm.nih.gov/41248686/). *Klin Monbl Augenheilkd*. [Review / Meta-Analysis]
Li R (2026). [PMID: 42054635](https://pubmed.ncbi.nlm.nih.gov/42054635/). *J Med Internet Res*. [Review / Meta-Analysis]
Geng Z (2026). [PMID: 40580389](https://pubmed.ncbi.nlm.nih.gov/40580389/). *Neurosci Bull*. [Basic Science / Preclinical]
Xue L (2026). [PMID: 41641813](https://pubmed.ncbi.nlm.nih.gov/41641813/). *Biomol Biomed*. [Review / Meta-Analysis]
Ishida H (2025). [PMID: 40149978](https://pubmed.ncbi.nlm.nih.gov/40149978/). *Biomolecules*. [Basic Science / Preclinical]
Hailaiti A (2025). [PMID: 40390126](https://pubmed.ncbi.nlm.nih.gov/40390126/). *Ital J Pediatr*. [Review / Meta-Analysis]
Zhang Y (2025). [PMID: 40234585](https://pubmed.ncbi.nlm.nih.gov/40234585/). *Commun Biol*. [Basic Science / Preclinical]
Bögershausen N (2025). [PMID: 40131364](https://pubmed.ncbi.nlm.nih.gov/40131364/). *JCI Insight*. [Basic Science / Preclinical]
Wei B (2025). [PMID: 39953544](https://pubmed.ncbi.nlm.nih.gov/39953544/). *Lipids Health Dis*. [Diagnostic / Biomarker]